Multiple hypointense vessels on susceptibility-weighted imaging predict early neurological deterioration in acute ischaemic stroke patients with severe intracranial large artery stenosis or occlusion receiving intravenous thrombolysis

• Published in: Stroke and vascular neurology Vol. 5; no. 4; pp. 361 - 367
• Main Authors: Liu, Yong-Lin, Yin, Han-Peng, Qiu, Dong-Hai, Qu, Jian-Feng, Zhong, Huo-Hua, Lu, Zhi-Hao, Wang, Fang, Liang, Man-Qiu, Chen, Yang-Kun
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd 01.12.2020; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Administration, Intravenous; Aged; Carotid Stenosis - complications; Carotid Stenosis - diagnostic imaging; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Female; Fibrinolytic Agents - administration & dosage; Fibrinolytic Agents - adverse effects; Homocysteine; Humans; Infarction, Middle Cerebral Artery - complications; Infarction, Middle Cerebral Artery - diagnostic imaging; Ischemic Stroke - diagnostic imaging; Ischemic Stroke - drug therapy; Ischemic Stroke - etiology; Male; Medical imaging; Middle Aged; MRI; Original Research; Patients; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Thrombolytic Therapy - adverse effects; Time Factors; Tissue Plasminogen Activator - administration & dosage; Tissue Plasminogen Activator - adverse effects; Treatment Outcome; Veins & arteries; MRI; stroke
• ISSN: 2059-8688; 2059-8696
• DOI: 10.1136/svn-2020-000343

Background and purposeEarly neurological deterioration (END) is a common feature in patients with acute ischaemic stroke (AIS) receiving thrombolysis. This study aimed to investigate whether the presence of multiple hypointense vessels (MHVs) on susceptibility-weighted imaging (SWI) could predict END in patients with the anterior circulation AIS treated with recombinant tissue plasminogen activator (r-tPA).MethodsThis was a retrospective study focusing on AIS patients suffering from symptomatic stenosis or occlusion of the middle cerebral artery or internal carotid artery with r-tPA treatment. We collected clinical variables and initial haematological and neuroimaging findings. MHVs were measured on SWI performed after intravenous thrombosis and were defined as the presence of a greater number of veins or veins of a larger diameter with greater signal loss on SWI than those of the contralesional haemisphere. The degree of hyperintensity of MHVs was classified into four grades: none, subtle, moderate and extensive. END was defined as an increase in the National Institutes of Health Stroke Scale score by 2 points during the first 48 hours after the onset of symptoms. Multivariate logistic regressions were conducted to investigate the predictors of END.ResultsThe study included 61 patients (51 males and 10 females) with a mean age of 62.4±12.6 years. Thirty-five (57.4%) patients presented with MHVs: 8 (13.1%) were graded as subtle MHVs, while 23 (37.7%) and 4 (6.6%) were graded as moderate or extensive MHVs, respectively. Twenty patients (32.8%) presented with END. Logistic regression analysis showed that compared with patients without MHVs, moderate MHVs (adjusted OR 5.446, 95% CI 1.360 to 21.800; p=0.017) and extensive MHVs (adjusted OR 15.240, 95% CI 1.200 to 193.544; p=0.036) were significantly associated with END.ConclusionsMHVs might be a useful predictor of END in AIS patients with symptomatic large artery stenosis or occlusion after r-tPA treatment.